SCHEMBL2364516

SCHEMBL2364516

O=C(O)N1CCC(c2ccc(F)cc2CO)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.44
NPC1 O15118 2/20 0.41
PTGDR2 Q9Y5Y4 2/20 0.41
OPRL1 P41146 3/20 0.40
RAB9A P51151 2/20 0.40
DPP4 P27487 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SCD5 Q86SK9 1/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
SLC9A1 P19634 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD11B1 P28845 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16825003 0.83 RBP4 (0.35) GRM5MEN1KMT2ACYP2C9SLC9A1
SCHEMBL16959916 0.82 OPRL1 (0.40) PTGDR2OPRL1
SCHEMBL2338827 0.81 GPR119 (0.52) DPP4ALDH1A1MAPTSMN1; SMN2CYP3A4
SCHEMBL27623434 0.81 NPC1 (0.44) GRM5NPC1PTGDR2OPRL1RAB9A
SCHEMBL14992618 0.81 RBP4 (0.43) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL2099816 0.80 RBP4 (0.47) NPC1PTGDR2RAB9AALDH1A1SMN1; SMN2
SCHEMBL27642929 0.78 SCD5 (0.44) GRM5NPC1PTGDR2RAB9ASCD5
SCHEMBL23034991 0.77 SCD5 (0.60) GRM5PTGDR2OPRL1SCD5CYP2C9
SCHEMBL17397790 0.77 NPC1 (0.39) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL6810820 0.76 IDO1 (0.45) NPC1PTGDR2OPRL1RAB9ASCD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358675-A1 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Theravance, Inc. (US) 2011-08-24 EP disclosed
WO-2010056941-A1 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS THERAVANCE, INC. (US) 2010-05-20 WO disclosed